CDNA
Diagnostics & Research · Healthcare
CEO, Board Member
2024-01-01–present
Board Member
CareDx, Inc. (CDNA)Equibles does not estimate personal net worth.
Get an email with a short summary when CareDx, Inc. publishes a filing, an earnings call transcript or a press release.
Get CDNA alertsJohn W. Hanna is recorded as Board Member at CareDx, Inc. (CDNA) since January 1, 2024 and CEO at CareDx, Inc. (CDNA). The newest filing on record that lists John W. Hanna as CEO at CareDx, Inc. (CDNA) is dated April 27, 2026. The newest filing on record that lists John W. Hanna as Board Member at CareDx, Inc. (CDNA) is dated April 28, 2025. CareDx, Inc. reported in an 8-K filed June 15, 2026 that John W. Hanna was appointed Class III director, effective June 11, 2026. CareDx, Inc. reported in an 8-K filed April 16, 2024 that John W. Hanna was appointed Class III director, effective April 15, 2024. CareDx, Inc. reported in an 8-K filed April 16, 2024 that John W. Hanna was appointed President and Chief Executive Officer, effective April 15, 2024. The proxy statement of CareDx, Inc. reports total compensation of $7,179,699 for John W. Hanna in fiscal 2025, including a base salary of $693,269. Disclosed compensation is on record for 2 fiscal years. CareDx, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at CareDx, Inc. includes Alexander L. Johnson (CEO), Michael D. Goldberg (Chairman and Board Member), Peter Maag, Ph.D. (Chairman) and 7 others.
“Each of the five nominees for director was elected to serve until the Company's 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified, or until such director's earlier death, resignation or removal.”
“The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).”
2024-01-01–present
Last confirmed April 28, 2025
Start not stated–present
Last confirmed April 27, 2026
CDNA
Diagnostics & Research · Healthcare
CEO, Board Member
2024-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CareDx, Inc. (CDNA) | President and Chief Executive Officer | $693,269 | $7,179,699 |
| 2024 | CareDx, Inc. (CDNA) | President and Chief Executive Officer | $454,327 | $9,424,329 |